Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T14:21:23.525Z.
Calculation as of: 2026-10-06T14:21:23.525Z.
Quote observation: 2026-10-06T14:20:17.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 3328ed161ff00c537a80d7dceb604f662f1c22c4e65cb57a824bf36ce3bbbe60
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
Corvus Pharmaceuticals, Inc.
Market Cap
$864.63M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$879.04M
Price/FCF Ratio
N/A
TTM Avg
27.25
3Y Avg
19.97
5Y Avg
19.97
Market Cap
$839.81M
Price/FCF Ratio
N/A
TTM Avg
12.01
3Y Avg
12.01
5Y Avg
12.01
Market Cap
$912.83M
Price/FCF Ratio
18.69
TTM Avg
13.52
3Y Avg
15.51
5Y Avg
16.87
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Corvus Pharmaceuticals, Inc. (CRVS) | $864.63M | N/A | N/A | N/A | N/A |
| Arbutus Biopharma Corp (ABUS)vs › | $879.04M | N/A | 27.25 | 19.97 | 19.97 |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $839.81M | N/A | 12.01 | 12.01 | 12.01 |
| Beta Bionics, Inc. (BBNX)vs › | $832.08M | N/A | N/A | N/A | N/A |
| Bioventus Inc. (BVS)vs › | $896.75M | 9.51 | 9.57 | 34.87 | 48.37 |
| Alumis Inc. (ALMS)vs › | $823.91M | N/A | N/A | N/A | N/A |
| Apnimed, Inc. (APMD)vs › | $817.17M | N/A | N/A | N/A | N/A |
| HealthStream, Inc. (HSTM)vs › | $912.83M | 18.69 | 13.52 | 15.51 | 16.87 |
| Jade Biosciences, Inc. (JBIO)vs › | $816.99M | N/A | N/A | N/A | N/A |
| InMode Ltd. (INMD)vs › | $808.41M | 9.24 | 9.91 | 9.93 | 15.12 |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
